Prevalence of orthostatic hypotension in Parkinson's disease

J M Senard, S Raï, M Lapeyre-Mestre, C Brefel, O Rascol, A Rascol, J L Montastruc, J M Senard, S Raï, M Lapeyre-Mestre, C Brefel, O Rascol, A Rascol, J L Montastruc

Abstract

Objectives: To investigate the prevalence of orthostatic hypotension and the nature of the postural events related to a fall in blood pressure in patients with Parkinson's disease.

Methods: Blood pressure was measured first in a supine position after a rest of at least 15 minutes and every minute during 10 minutes of an active standing up procedure. Orthostatic hypotension was considered as present when a fall of at least 20 mm Hg of systolic blood pressure was recorded. Postural events which occurred during the standing test were identified from a questionnaire and self reporting. Statistical analysis was performed to determine the relation between orthostatic hypotension and disease characteristics (duration, severity) and the use of antiparkinsonian drugs. Ninety one consecutive patients with Parkinson's disease (48 women, 43 men, mean age 66 (SD 9) years) participated to the study.

Results: A fall of at least 20 mm Hg of systolic blood pressure was found in 58.2% of the patients. Orthostatic hypotension was asymptomatic in 38.5% and associated with postural events in 19.8% of the patients. Symptomatic (but not asymptomatic) orthostatic hypotension was related to duration and severity of the disease and with the use of higher daily levodopa and bromocriptine doses. The analysis of the relation between the postural symptoms (and the need for standing test abortion) with the fall in systolic blood pressure allowed the identification of six clinical criteria specific of orthostatic hypotension. A direct relation between the postural changes in systolic blood pressure and the number of clinical events in this clinical scale was found.

Conclusion: The frequency of orthostatic hypotension in Parkinson's disease is high and it is possible to establish a clinical rating scale which could be used to assess the effects of drugs employed in the management of orthostatic hypotension.

References

    1. Lancet. 1972 Jan 1;1(7740):4-6
    1. Neurology. 1967 May;17(5):427-42
    1. Neurology. 1983 Apr;33(4):463-7
    1. Acta Neurol Scand. 1985 Jan;71(1):37-42
    1. Neurology. 1986 Jan;36(1):73-5
    1. Eur Neurol. 1987;26(2):104-12
    1. Neurology. 1987 Jul;37(7):1173-8
    1. J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):745-52
    1. Acta Neurol Scand. 1990 Apr;81(4):346-8
    1. Eur J Clin Invest. 1990 Dec;20(6):613-9
    1. Clin Neuropharmacol. 1991 Feb;14(1):84-90
    1. Eur Neurol. 1991;31 Suppl 1:41-7
    1. J Neurol. 1991 Jul;238(4):195-9
    1. J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
    1. Arch Intern Med. 1992 May;152(5):1058-64
    1. Eur Neurol. 1992;32(3):134-40
    1. Hypertension. 1992 Jun;19(6 Pt 1):508-19
    1. Clin Auton Res. 1992 Apr;2(2):99-104
    1. Clin Auton Res. 1991 Jun;1(2):147-55
    1. J Neurol Neurosurg Psychiatry. 1993 Oct;56(10):1090-5
    1. J Clin Pharmacol. 1994 May;34(5):394-402
    1. Brain. 1994 Aug;117 ( Pt 4):835-45
    1. Arch Intern Med. 1995 May 8;155(9):930-5
    1. Neurology. 1995 Apr;45(4 Suppl 5):S6-11
    1. Drugs Aging. 1995 Mar;6(3):219-28
    1. Clin Auton Res. 1995 Apr;5(2):85-9
    1. Acta Cardiol. 1965;20(4):332-48
    1. Acta Neurol Scand Suppl. 1972;51:105-7

Source: PubMed

3
購読する